022 24172311
Sections
Search
DealCurry
Equity
Venture Capital
Private Equity
M&A

Banner
DataBoard Demo
Mergers & Acquisitions | 17 August 2012

KKR, Novartis, Pfizer In Race To Acquire Strides' Unit

by Paritosh Gajjar
KKR, Novartis, Pfizer In Race To Acquire Strides' Unit
Share on Social Media Email Facebook Twitter Linkedin
 
@Paritosh
Strides Arcolabs' injectable-drugs unit, Agila Specialties Private Limited is up for sale and 'serious bidders' for the asset are Novartis and Pfizer along with U.S buyout fund KKR, ET stated.

Strides is expecting to receive anywhere between $1.6-2 Bn for the unit - more than twice its market value.

Strides provides Pfizer with generic versions of off-patent drugs through a partnership announced in 2010.

Orbit Corp To Raise Funds - Selling Multiple Projects

Orbit Corp To Raise Funds - Selling Multiple Projects

Orbit Corp is planning to sell multiple planned projects in Mumbai to raise funds and reduce debt, according to Mint.

Read More...

Clinical-stage specialty bio-pharmaceutical company Vyome Biosciences raises $14 million

Clinical-stage specialty bio-pharmaceutical company Vyome Biosciences raises $14 million

The clinical-stage specialty bio-pharmaceutical company Vyome Biosciences Private Limited has raises $14 million in Series-C financing round. The financing round was led by a prominent New York based life sciences fund Perceptive Advisors. Apart from that the funding round saw participation of a Boston-based venture capital Romulus Capital along with existing investors.

Read More...
Subscribe
Enter your Email address
to receive all the news